E
ZYUS Life Sciences Corporation ZLSCF
$0.60 -$0.06-9.09%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 22.22% 50.44% 46.62% 28.93% 14.60%
Total Other Revenue -- -- -- -- --
Total Revenue 22.22% 50.44% 46.62% 28.93% 14.60%
Cost of Revenue -39.14% 60.57% 100.48% 331.81% 43.25%
Gross Profit 365.18% 42.68% 16.22% -383.85% -45.89%
SG&A Expenses -27.15% -20.81% 13.51% 105.89% 21.35%
Depreciation & Amortization -6.71% 18.57% -22.13% 5.18% -32.18%
Other Operating Expenses -17.76% -4.50% 95.91% 2,027.59% -66.21%
Total Operating Expenses -7.76% -8.40% 2.46% 122.59% 0.80%
Operating Income 8.51% 9.29% -1.37% -124.72% -0.49%
Income Before Tax 8.17% 48.77% 30.63% -403.84% 44.23%
Income Tax Expenses 20.38% 20.51% -6.78% -607,871.43% -20.77%
Earnings from Continuing Operations 8.11% 48.83% 30.75% -307.55% 44.38%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 8.11% 48.83% 30.75% -307.55% 44.38%
EBIT 8.51% 9.29% -1.37% -124.72% -0.49%
EBITDA 8.94% 13.08% -11.20% -132.76% -13.59%
EPS Basic 11.16% 66.98% 62.39% -124.17% 69.29%
Normalized Basic EPS 11.03% 58.09% 62.20% 31.28% 57.03%
EPS Diluted 11.16% 65.91% 60.02% -125.57% 69.29%
Normalized Diluted EPS 11.03% 58.09% 62.20% 31.28% 57.03%
Average Basic Shares Outstanding 3.38% 54.88% 83.86% 81.77% 81.21%
Average Diluted Shares Outstanding 3.38% 54.88% 83.86% 81.77% 81.21%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings